565 related articles for article (PubMed ID: 12122494)
1. M(3) receptor antagonism by the novel antimuscarinic agent solifenacin in the urinary bladder and salivary gland.
Ikeda K; Kobayashi S; Suzuki M; Miyata K; Takeuchi M; Yamada T; Honda K
Naunyn Schmiedebergs Arch Pharmacol; 2002 Aug; 366(2):97-103. PubMed ID: 12122494
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo tissue selectivity profile of solifenacin succinate (YM905) for urinary bladder over salivary gland in rats.
Ohtake A; Ukai M; Hatanaka T; Kobayashi S; Ikeda K; Sato S; Miyata K; Sasamata M
Eur J Pharmacol; 2004 May; 492(2-3):243-50. PubMed ID: 15178371
[TBL] [Abstract][Full Text] [Related]
3. Comparison of muscarinic receptor selectivity of solifenacin and oxybutynin in the bladder and submandibular gland of muscarinic receptor knockout mice.
Ito Y; Oyunzul L; Yoshida A; Fujino T; Noguchi Y; Yuyama H; Ohtake A; Suzuki M; Sasamata M; Matsui M; Yamada S
Eur J Pharmacol; 2009 Aug; 615(1-3):201-6. PubMed ID: 19446545
[TBL] [Abstract][Full Text] [Related]
4. Comparison of in vitro selectivity profiles of solifenacin succinate (YM905) and current antimuscarinic drugs in bladder and salivary glands: a Ca2+ mobilization study in monkey cells.
Kobayashi S; Ikeda K; Miyata K
Life Sci; 2004 Jan; 74(7):843-53. PubMed ID: 14659973
[TBL] [Abstract][Full Text] [Related]
5. Comparative in vivo uroselectivity profiles of anticholinergics, tested in a novel anesthetized rabbit model.
Naruganahalli KS; Sinha S; Hegde LG; Meru AV; Chugh A; Kumar N; Gupta JB; Ray A
Eur J Pharmacol; 2007 Oct; 572(2-3):207-12. PubMed ID: 17610864
[TBL] [Abstract][Full Text] [Related]
6. Muscarinic receptor binding, plasma concentration and inhibition of salivation after oral administration of a novel antimuscarinic agent, solifenacin succinate in mice.
Oki T; Sato S; Miyata K; Yamada S
Br J Pharmacol; 2005 May; 145(2):219-27. PubMed ID: 15753946
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological effects of solifenacin on human isolated urinary bladder.
Masunaga K; Yoshida M; Inadome A; Murakami S; Sugiyama Y; Satoji Y; Maeda Y; Ueda S
Pharmacology; 2008; 82(1):43-52. PubMed ID: 18434763
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological characterization of a new antimuscarinic agent, solifenacin succinate, in comparison with other antimuscarinic agents.
Ohtake A; Saitoh C; Yuyama H; Ukai M; Okutsu H; Noguchi Y; Hatanaka T; Suzuki M; Sato S; Sasamata M; Miyata K
Biol Pharm Bull; 2007 Jan; 30(1):54-8. PubMed ID: 17202659
[TBL] [Abstract][Full Text] [Related]
9. Effects of imidafenacin (KRP-197/ONO-8025), a new anti-cholinergic agent, on muscarinic acetylcholine receptors. High affinities for M3 and M1 receptor subtypes and selectivity for urinary bladder over salivary gland.
Kobayashi F; Yageta Y; Segawa M; Matsuzawa S
Arzneimittelforschung; 2007; 57(2):92-100. PubMed ID: 17396619
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological properties of TD-6301, a novel bladder selective muscarinic receptor antagonist.
McNamara A; Pulido-Rios MT; Sweazey S; Obedencio GP; Thibodeaux H; Renner T; Armstrong SR; Steinfeld T; Hughes AD; Wilson RD; Jasper JR; Mammen M; Hegde SS
Eur J Pharmacol; 2009 Mar; 605(1-3):145-52. PubMed ID: 19168050
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and antimuscarinic properties of quinuclidin-3-yl 1,2,3,4-tetrahydroisoquinoline-2-carboxylate derivatives as novel muscarinic receptor antagonists.
Naito R; Yonetoku Y; Okamoto Y; Toyoshima A; Ikeda K; Takeuchi M
J Med Chem; 2005 Oct; 48(21):6597-606. PubMed ID: 16220976
[TBL] [Abstract][Full Text] [Related]
12. Functional selectivity of muscarinic receptor antagonists for inhibition of M3-mediated phosphoinositide responses in guinea pig urinary bladder and submandibular salivary gland.
Nelson CP; Gupta P; Napier CM; Nahorski SR; Challiss RA
J Pharmacol Exp Ther; 2004 Sep; 310(3):1255-65. PubMed ID: 15140916
[TBL] [Abstract][Full Text] [Related]
13. Enantiomers of oxybutynin: in vitro pharmacological characterization at M1, M2 and M3 muscarinic receptors and in vivo effects on urinary bladder contraction, mydriasis and salivary secretion in guinea pigs.
Noronha-Blob L; Kachur JF
J Pharmacol Exp Ther; 1991 Feb; 256(2):562-7. PubMed ID: 1993995
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological effects of imidafenacin (KRP-197/ONO-8025), a new bladder selective anti-cholinergic agent, in rats. Comparison of effects on urinary bladder capacity and contraction, salivary secretion and performance in the Morris water maze task.
Kobayashi F; Yageta Y; Yamazaki T; Wakabayashi E; Inoue M; Segawa M; Matsuzawa S
Arzneimittelforschung; 2007; 57(3):147-54. PubMed ID: 17469649
[TBL] [Abstract][Full Text] [Related]
15. Characterization of muscarinic receptor binding and inhibition of salivation after oral administration of tolterodine in mice.
Oki T; Maruyama S; Takagi Y; Yamamura HI; Yamada S
Eur J Pharmacol; 2006 Jan; 529(1-3):157-63. PubMed ID: 16316647
[TBL] [Abstract][Full Text] [Related]
16. Tolterodine--a new bladder-selective antimuscarinic agent.
Nilvebrant L; Andersson KE; Gillberg PG; Stahl M; Sparf B
Eur J Pharmacol; 1997 May; 327(2-3):195-207. PubMed ID: 9200560
[TBL] [Abstract][Full Text] [Related]
17. Effects of solifenacin succinate (YM905) on detrusor overactivity in conscious cerebral infarcted rats.
Suzuki M; Ohtake A; Yoshino T; Yuyama H; Hayashi A; Ukai M; Okutsu H; Noguchi Y; Sato S; Sasamata M
Eur J Pharmacol; 2005 Apr; 512(1):61-6. PubMed ID: 15814091
[TBL] [Abstract][Full Text] [Related]
18. In vivo demonstration of M3 muscarinic receptor subtype selectivity of darifenacin in mice.
Yamada S; Maruyama S; Takagi Y; Uchida S; Oki T
Life Sci; 2006 Dec; 80(2):127-32. PubMed ID: 16996089
[TBL] [Abstract][Full Text] [Related]
19. Comparison of receptor binding characteristics of commonly used muscarinic antagonists in human bladder detrusor and mucosa.
Mansfield KJ; Chandran JJ; Vaux KJ; Millard RJ; Christopoulos A; Mitchelson FJ; Burcher E
J Pharmacol Exp Ther; 2009 Mar; 328(3):893-9. PubMed ID: 19029429
[TBL] [Abstract][Full Text] [Related]
20. Comparison of oxybutynin and its active metabolite, N-desethyl-oxybutynin, in the human detrusor and parotid gland.
Waldeck K; Larsson B; Andersson KE
J Urol; 1997 Mar; 157(3):1093-7. PubMed ID: 9072550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
